In vitro shape changes of human erythrocyte membranes.
D000255:Adenosine Triphosphate / Q000032:analysis; D000535:Aluminum / Q000494:pharmacology; D002462:Cell Membrane / Q000187:drug effects; D002729:Chloromercuribenzoates / Q000494:pharmacology; D002746:Chlorpromazine / Q000494:pharmacology; D004912:Erythrocytes / Q000032:analysis / Q000166:cytology* / Q000187:drug effects; D000431:Ethanol / Q000494:pharmacology; D005033:Ethylmaleimide / Q000494:pharmacology; D006358:Hot Temperature; D006801:Humans; D008855:Microscopy, Electron, Scanning; D009578:Nitrobenzenes; D009994:Osmolar Concentration; D009996:Osmotic Fragility; D010713:Phosphatidylcholines / Q000494:pharmacology; D011319:Primaquine / Q000494:pharmacology; D012503:Saponins / Q000494:pharmacology; D012965:Sodium Chloride; D013053:Spectrophotometry; D013451:Sulfonic Acids; D013501:Surface-Active Agents / Q000494:pharmacology
D002729:Chloromercuribenzoates; D009578:Nitrobenzenes; D010713:Phosphatidylcholines; D012503:Saponins; D013451:Sulfonic Acids; D013501:Surface-Active Agents; D000431:Ethanol; D012965:Sodium Chloride; D000255:Adenosine Triphosphate; D000535:Aluminum; D011319:Primaquine; D005033:Ethylmaleimide; D002746:Chlorpromazine